National Institutes of Health: Infections trials

The registry lists 375 Infections studies with National Institutes of Health as lead sponsor. 16 are open to participants now and 43 have results posted.

Phase 1 89Phase 2 100Phase 3 47Phase 4 7No phase 144(a study in two phases counts in both)

Studies

Page 2 of 4. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected WomenCompletedNCT00594373Phase 1
• Influenza in People With Normal and Weakened Immune SystemsCompletedNCT00533182
• Study of Chlorhexidine as the Hub Antiseptic to Prevent Catheter Related Infections in Newborn InfantsStatus unknownNCT00516360Phase 4
• Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and AfricaWithdrawnNCT00498056Phase 2
• HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of BiomarkersCompletedNCT00491335
• Effects of Creatine and Resistance Exercise Training in People With HIV InfectionCompletedNCT00484627Phase 2
• Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy AdultsCompletedNCT00472719Phase 1
• Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African AdultsWithdrawnNCT00415649Phase 2
• Determining Responses to Two Different Vaccines in HIV and HCV Infected IndividualsCompletedNCT00393276Phase 1
• Examining Factors That May Influence Resistance to HIV-1 InfectionCompletedNCT00351442
• Changes in HIV Viral Load in Patients Undergoing Treatment for FilariasisCompletedNCT00344279
• New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis PneumoniaCompletedNCT00342589
• Host Response to Infection and Treatment in Lymphatic Filarial Disease in IndiaCompletedNCT00342576
• Surveillance of Streptococcal Infections in Children in IndiaCompletedNCT00342199
• The Effect of Parasitic Worm Infections on the Immune Response to Tuberculosis BacteriaCompletedNCT00342017
• Immune Response Regulation in People Infected Concurrently With Malarial and Filarial ParasitesCompletedNCT00341666
• Coated Endotracheal Tube and Mucus Shaver to Prevent Hospital-Acquired InfectionsCompletedNCT00341354Phase 2
• Doxycycline to Treat Mansonella Perstans Infection in Patients With and Without Lymphatic FilariasisCompletedNCT00340691Phase 2
• HLA and KIR Associations With Infectious Viral Agents in an HIV Cohort of Women (WIHS)CompletedNCT00339430
• Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected AdultsStatus unknownNCT00331448
• CMV Infection in Adolescent MalesTerminatedNCT00302029
• Acute HIV Infection Observational StudyCompletedNCT00296660
• Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and EcuadorCompletedNCT00279331
• Prevalence of HIV and Other Sexually Transmitted Infections Among Female Sex Workers and Miners in Honghe Prefecture, Yunnan Province, ChinaCompletedNCT00278499
• Bacterial Pulmonary Infection in PICUCompletedNCT00271531
• Controlling Acute or Early HIV Infection With Antiretroviral Drugs, Without a Candidate Vaccine.As Reported Previously, the Candidate Vaccie Was Not Provided by the Maufacturer as PromisedCompletedNCT00238459
• Infectious Agents in Pediatric Crohn'sCompletedNCT00237055
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
• Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical TrialsCompletedNCT00183287
• Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV InfectionCompletedNCT00183261Phase 2
• Impact of Gender on PatientsCompletedNCT00170560
• Acute Viral Respiratory Infections in ElderlyTerminatedNCT00170495
• gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent FemalesCompletedNCT00133497Phase 2
• Micronutrients and Enteric Infections in African ChildrenCompletedNCT00133419Phase 2
• Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV InfectionCompletedNCT00125099Phase 1/2
• Adjuvant Cytokine Therapy to Treat Pulmonary Mycobacterium Avium Complex InfectionCompletedNCT00111397Phase 1
• "Prime-Boost" Vaccine Schedule for Prevention of HIV InfectionCompletedNCT00109629Phase 1
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in SenegalCompletedNCT00100568Not applicable
• RSV Challenge in Healthy AdultsCompletedNCT00100373Not applicable
• Effects of Cranberry-Containing Products in Women With Recurrent Urinary Tract Infections (UTIs)Status unknownNCT00100061Phase 2
• Retrovirus Epidemiology Donor Study-II (REDS-II)CompletedNCT00097006
• Hormonal Contraception and Risk of Chlamydia and GonorrheaTerminatedNCT00091728
• Identification of the Cranberry Juice Compounds That Prevent Urinary Tract InfectionsCompletedNCT00087828Not applicable
• Three Month Course of Anti-HIV Medications for People Recently Infected With HIVWithdrawnNCT00087464Not applicable
• Long-term Follow-up of HIV Infected Patients Identified During Early InfectionCompletedNCT00086372
• Interactions Between Cranberry Juice and Antibiotics Used to Treat Urinary Tract InfectionsCompletedNCT00084201Not applicable
• Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIVWithdrawnNCT00084032Not applicable
• Increasing Condom Use in People at Risk for HIV InfectionStatus unknownNCT00080093Not applicable
• Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in CambodiaWithdrawnNCT00078182Phase 2/3
• A Study of Acyclovir to Help Prevent HIV Infection in People With Genital HerpesCompletedNCT00076232Phase 3
• BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in WomenCompletedNCT00074425Phase 2
• Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and AdolescentsCompletedNCT00073424
• Immune Function of Infants With HIVCompletedNCT00073229
• VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious DiseasesCompletedNCT00068926
• Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell TransplantationCompletedNCT00064311Phase 1/2
• Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal InfectionsCompletedNCT00059878Phase 2
• Tuberculosis in HIV Infected Patients in UgandaCompletedNCT00057421Phase 2
• When to Start Anti-HIV Drugs in Patients With Opportunistic InfectionsCompletedNCT00055120Phase 4
• Treatment of Acute HIV Infection to Preserve Immune FunctionCompletedNCT00055094
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive PatientsCompletedNCT00050895Phase 3
• Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 InfectionCompletedNCT00050856Phase 3
• Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV InfectionCompletedNCT00050284
• A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV InfectionCompletedNCT00038272Phase 2
• Prevalence of Hepatitis C Virus Infection in HIV-Infected ChildrenCompletedNCT00037076
• Posaconazole to Treat Invasive Fungal InfectionsCompletedNCT00033982Phase 3
• Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant PatientsTerminatedNCT00031473Phase 3
• Valganciclovir in Congenital CMV InfantsCompletedNCT00031434Phase 1/2
• Neonatal CMV-Ganciclovir Follow-up StudyCompletedNCT00031421
• Role of Toxins in Lung Infections Caused by Pseudomonas AeruginosaCompletedNCT00027183
• Surveillance of Fungal Infections in Bone Marrow/Stem Cell and Organ Transplant RecipientsCompletedNCT00026767
• Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral LoadCompletedNCT00025922
• Intermittent vs. Continuous HAART to Treat Chronic HIV InfectionCompletedNCT00025909Phase 3
• Tenofovir Disoproxil Fumarate to Treat Pediatric HIVCompletedNCT00024986Phase 1
• Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
• A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex InfectionsCompletedNCT00021567Phase 2
• Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV DrugsCompletedNCT00017771
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During PregnancyCompletedNCT00017719Phase 3
• Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionCompletedNCT00015652Not applicable
• Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV InfectionCompletedNCT00013520Phase 3
• Kidney Transplant for HIV-Infected Patients in Renal FailureCompletedNCT00009009Phase 2
• A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)CompletedNCT00008463Phase 2
• Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV PatientsCompletedNCT00007202Phase 2
• Vaccinia Immune Globulin in Treating or Preventing Vaccinal InfectionWithdrawnNCT00006630Phase 1
• Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting MedicationWithdrawnNCT00006578Not applicable
• Capravirine to Treat Children With HIV InfectionCompletedNCT00006519Phase 1
• Effectiveness of Anti-HIV Drugs in Patients Who Have Not Received Previous Anti-HIV Drugs During Different Stages of HIV InfectionCompletedNCT00006443Not applicable
• Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIVCompletedNCT00006441Not applicable
• A Test of Behavioral Intervention for Women at High Risk for HIV InfectionCompletedNCT00006440
• A Study of Patients Who Recently Have Been Infected With HIVWithdrawnNCT00006415
• Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their NewbornsCompletedNCT00006396Phase 3
• Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV InfectionWithdrawnNCT00006339Phase 2
• Long-Term Effects of HIV Exposure and Infection in ChildrenCompletedNCT00006304
• Studies of HIV-1 Infection in Newly Infected Individuals in Southern AfricaCompletedNCT00006298
• A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV InfectionCompletedNCT00006154Phase 3
• Effectiveness of Adding Remune to Your Current Anti-HIV Drug CombinationTerminatedNCT00006153Phase 1
• Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIVCompletedNCT00006145Phase 3
• Voriconazole to Prevent Systemic Fungal Infections in ChildrenCompletedNCT00005912Phase 1
• A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) InfectionCompletedNCT00005572
• Infection and Cardiovascular DiseaseCompletedNCT00005547